Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers.


HLA and IL-28B genes were independently associated with severity of HCV-related liver disease. We investigated the effects of these combined genetic factors on post-transplant survival in HCV-infected recipients, aiming to provide new data to define the optimal timing of novel antiviral therapies in the transplant setting. HLA-A/B/DRB1 alleles and IL-28B… (More)
DOI: 10.1111/tri.12795


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics